Research > Epidemiology, Infectious Diseases and Public Health

Pharmacology & Molecular Microbiology

Number of publications
223
Publications search
  • Rius, J.; Zapata, A.; Ahmad, F.; Schoeneneberger, J.A.

    Use of a pharmacotherapeutic reconciliation process based on "STOPP" criteria applied to patients older than 70 years old admitted in the hospital

    Circular Farmaceutica 73 13-18. .

  • Muniesa, M.; March, A.; Sánchez-De-La-Torre, M.; Huerva, V.; Jurjo, C.; Barbé, F.

    Erratum: Corneal biomechanical properties in floppy eyelid syndrome (Cornea (2015) 34 (521-524))

    Cornea 34 19-19. .

    [doi:10.1097/ICO.0000000000000488]

  • Huerva V; Sánchez MC; Ascaso FJ; Soldevila J

    Late postoperative capsular block syndrome: a case series studied before and after Nd:YAG laser posterior capsulotomy

    EUROPEAN JOURNAL OF OPHTHALMOLOGY 25 27-32. .

    [doi:10.5301/ejo.5000507]

  • Martinez-Alonso, M; Dusso, A; Ariza, G; Nabal, M

    The effect on quality of life of vitamin D administration for advanced cancer treatment (VIDAFACT study): protocol of a randomised controlled trial

    Bmj Open 4 -. .

    [doi:10.1136/bmjopen-2014-006128]

  • Huerva V

    Re: Nanji et al.: Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications (Ophthalmology 2014;121:994-1000)

    Ophthalmology 121 66-66. .

    [doi:10.1016/j.ophtha.2014.06.046]

  • Huerva, Valentin; Ascaso, Francisco J.; Grzybowski, Andrzej

    Infliximab for Peripheral Ulcerative Keratitis Treatment

    Medicine 93 -. .

    [doi:10.1097/MD.0000000000000176]

  • Zheng, Q.; Peskoe, S.B.; Ribas, J.; Rafiqi, F.; Kudrolli, T.; Meeker, A.K.; De Marzo, A.M.; Platz, E.A.; Lupold, S.E.

    Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy

    Prostate 74 1655-1662. .

    [doi:10.1002/pros.22883]

  • Mattiolo, P.; Barbero-Farran, A.; Amigó, J.; Ripamonti, M.; Ribas, J.; Boix, J.

    Cell death induced by 2-phenylethynesulfonamide uncovers a pro-survival function of BAX

    CANCER LETTERS 354 115-121. .

    [doi:10.1016/j.canlet.2014.07.037]

  • Mattiolo, P.; Barbero-Farran, A.; Yuste, V.J.; Boix, J.; Ribas, J.

    2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53

    BIOCHEMICAL PHARMACOLOGY 91 301-311. .

    [doi:10.1016/j.bcp.2014.08.005]

  • Nabal M; Bescos M; Barcons M; Torrubia P; Trujillano J; Requena A

    New Symptom-Based Predictive Tool for Survival at Seven and Thirty Days Developed by Palliative Home Care Teams

    JOURNAL OF PALLIATIVE MEDICINE 17 1158-1163. .

    [doi:10.1089/jpm.2013.0630]

  • Nita M; Grzybowski A; Ascaso FJ; Huerva V

    Age-Related Macular Degeneration in the Aspect of Chronic Low-Grade Inflammation (Pathophysiological ParaInflammation)

    Mediators of Inflammation 2014 930671-930671. .

    [doi:10.1155/2014/930671]

  • Ascaso FJ; Huerva V; Grzybowski A

    The Role of Inflammation in the Pathogenesis of Macular Edema Secondary to Retinal Vascular Diseases

    Mediators of Inflammation 2014 432685-432685. .

    [doi:10.1155/2014/432685]